- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01483235
Reduced Cardiac Rehabilitation Program (rCRP)
Design, Implementation and Evaluation of a Reduced Cardiac Rehabilitation Program
Standard cardiac rehabilitation programs (sCRP) aim to improve risk factors for heart disease such as high blood pressure, weight control, exercise and diet in order to decrease the chances of having heart problems in the future. These programs decrease morbidity and mortality but face important challenges: 1) Long waiting lists to participate in these programs. For example, St. Paul's Hospital has an intake capacity of 480 patients per year. Patients usually wait one to three months to start the program. 2) There is a vast heterogeneity of patients within the same program, from those that have never experienced heart problems to those that have already had a heart attack, chest pain or stroke. Therefore, patients with different medical problems receive the same treatment. 3) Facilities can be inconveniently located which leads to transportation difficulties, 4) The program is time consuming and classes are held in working times, 5) Shortly after completion, patients seem to lose what they have gained in the program. These caveats need to be addressed to improve the efficacy, delivery and capacity of sCRP for the increasing population of patients with heart disease.
The investigators want to compare a reduced cardiac rehabilitation program (rCRP) with the standard cardiac rehabilitation program (sCRP) in patients with risk factors for heart disease as well as patients that already suffer from this condition, including those at higher risk. The rCRP will offer the same services as the sCRP; the only difference is the number of hospital based exercise sessions. While the sCRP offers 32 hospital based supervised exercise sessions, the rCRP will offer 10 hospital based exercise sessions. The rCRP would be a 'middle of the road alternative program' that would have the benefits of a hospital based program and the flexibility of a home based intervention. The rCRP would offer an alternative for patients that do not need constant supervision and would allow the sCRP health care team to focus on those patients who have more serious heart conditions. The rCRP would be a unique intervention because it integrates a less intensive cardiac rehabilitation into the pre-existing sCRP model. This alternative would help overcome the caveats of standard cardiac rehabilitation programs.
Study Overview
Status
Conditions
Detailed Description
This study is a two group randomized controlled trial, non-inferiority design, where the rCRP (intervention group) will be compared with the sCRP (control group). Eligible patients will be asked to participate in the study at the cardiac rehabilitation program intake clinic. Consenting participants will be asked to sign an informed consent and undergo a baseline assessment. This assessment will consist of a medical history, exercise capacity (stress test), blood test, blood pressure, anthropometric measurements, lifestyle behaviours and psychosocial measurements. The baseline assessment will be done before participants start the program. Consecutively, randomization will take place stratified according to gender to either the sCRP or rCRP. The same assessment called exit assessment will be performed at four to six months from baseline, at the cardiac rehabilitation program exit clinic (at program completion) and at 16 to 20 months from baseline (one year follow-up from cardiac rehabilitation program completion) to assess the immediate and sustainable effect, respectively.
The following research questions will be addressed:
- Is the reduced cardiac rehabilitation program (intervention group) as effective as the standard cardiac rehabilitation program (control group) for improving exercise capacity and ischemic heart disease risk factors at both program completion (four to six months from baseline) and at one year from program completion (16 to 20 months from baseline)?
- Will the reduced cardiac rehabilitation program have better adherence than the standard cardiac rehabilitation program?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V6Z 1Y6
- St Paul's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and women (equal distribution) with risk factors for ischemic heart disease (primary prevention) or documented ischemic heart disease (secondary prevention) accepted in the cardiac rehabilitation program of St. Paul's Hospital.
- Patients with documented ischemic heart disease (secondary prevention) classified as low and moderate risk according to the AACVPR risk stratification criteria for cardiac patients.
Exclusion Criteria:
- Patients with documented ischemic heart disease (secondary prevention)at high risk according to the AACVPR risk stratification criteria for cardiac patients.
Patients will also be excluded if they have the following:
- Uncontrolled metabolic factors (renal failure, uncontrolled diabetes, endocrinopathies
- Scheduled revascularization
- Unable to provide informed consent
- Unlikely to survive due to non cardiac issues
- Psychiatric conditions that would interfere with compliance.
- Center for Epidemiologic Studies Depression scale higher than 16 points.
- Those coming to the cardiac rehabilitation program due to congenital heart disease with no risk factors for ischemic heart disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Reduced cardiac rehabilitation (rCRP)
The rCRP is the intervention group, compared to the standard cardiac rehabilitation program group (sCRP).
The rCRP will have the core elements of the sCRP, that is, in-hospital exercise sessions, dietary counseling, educational sessions, follow-up with the cardiologist, dietician and exercise specialist.
The only difference will be the number of in-hospital exercise sessions (10 sessions for the rCRP v/s 32 sessions for the sCRP).
Patients from rCRP will receive individual exercise guidelines, an educational package with questions of the week and a diary to record their exercise sessions (logbook), that will serve as a self-monitoring system.
|
The rCRP is a comprehensive intervention that will keep the same nature of therapies as the standard cardiac rehabilitation group (sCRP).
The difference with the sCRP resides in the number of hospital based exercise sessions; instead of 32 sessions there will be 10 sessions spread throughout the 4 months of intervention (hence, not a shorter program).
The rCRP intervention works within the sCRP.
Hence, those randomized to the rCRP will be supervised in the same facility and by the same clinical staff as those in the sCRP.
Patients from rCRP will receive individual exercise guidelines, an educational package with questions of the week and a diary to record their exercise sessions (logbook), that will serve as a self-monitoring system.
Other Names:
|
Active Comparator: Standard cardiac rehabilitation (sCRP)
The standard cardiac rehabilitation (sCRP) follows the standard cardiac rehabilitation program model of a four-month period.
Patients receive an initial intake evaluation by a cardiologist, nurse, exercise specialist and dietitian before starting the program.
The program consists of 32, twice weekly in-hospital exercise sessions, educational sessions, nutritional counseling, medical care, psychological screening and smoking cessation if needed.
|
The standard cardiac rehabilitation is a multidisciplinary four-month intervention to modify ischemic heart disease risk factors and lifestyle behaviours.
These programs aim to reduce morbidity and mortality by improving adherence to regular physical activity, a healthy diet and smoking cessation, as well as risk factor modification.
Patients receive an initial intake evaluation by a cardiologist, nurse,exercise specialist and dietitian before starting the program.
The program consists of 32, twice weekly in-hospital exercise sessions, educational sessions, nutritional counselling, medical care, psychological screening and smoking cessation if needed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise Capacity
Time Frame: Data collection to be completed in September 2011
|
Exercise capacity will be determined through a symptom-limited maximal treadmill exercise test using the Bruce protocol and reported as total time in seconds in the treadmill.
Participants will undergo continuous 12-lead ECG monitoring during the test.
Participants will have their baseline, exit(program completion) and one-year (16 to 20 months from baseline) exercise stress tests conducted at the ECG stress laboratory at St. Paul's Hospital.
|
Data collection to be completed in September 2011
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic risk factors.
Time Frame: Data collection to be completed by September 2011
|
Total cholesterol, HDL-C, triglycerides and blood glucose will be assessed from fasting blood samples.
The Friedewald equation will be used to calculate LDL-C.
To assess for change in global risk score, the Framingham risk score and the Progression of Disease risk score will be used for primary and secondary prevention patients respectively.
Blood pressure will be measured with a manual sphyngomanometer.
These outcomes will be assessed at baseline (program intake), program completion (four to six months from baseline) and at 16 to 20 months from baseline.
|
Data collection to be completed by September 2011
|
Lifestyle
Time Frame: Data collection to be completed in September 2011
|
Leisure time physical activity will be determined by the four-week modified Minnesota LTPA questionnaire and reported as the average weekly kilocalories (kcal/wk) expended through physical activity and exercise.
Diet will be reported as percent daily kilocalories for fat, protein and carbohydrates using a three-day food record.
Smoking status will be assessed by self-report.
These outcomes will be measured at baseline (program intake), program completion (four to six months from baseline) and at 16 to 20 months from baseline.
|
Data collection to be completed in September 2011
|
Psychosocial measures
Time Frame: Data to be collected by September 2011
|
Health related Quality of life will be assessed by the Euro Quality of Life questionnaire.
Self-efficacy will be assessed with the self-efficacy questionnaire that has two components: a general self-efficacy assessment and exercise-specific assessment.
These outcomes will be measured at baseline (program intake), program completion (four to six months from baseline)and at 16 to 20 months from baseline.
|
Data to be collected by September 2011
|
Anthropometry
Time Frame: Data to be collected by September 2011
|
Body mass index will be calculated from weight in kilograms divided by height in metres squared.
Waist circumference will be recorded in centimetres, taken at the point of maximal narrowing following a normal expiration.
Hip circumference will be recorded in centimetres taken at the point of maximal gluteal protuberance.
Waist to hip ratio will be calculated by simple division.
These outcomes will be measured at baseline (program intake), program completion (four to six months from baseline) and at 16 to 20 months from baseline.
|
Data to be collected by September 2011
|
Program adherence
Time Frame: Data collection to be completed in September 2011
|
Assessed as percent attendance to in-hospital sessions.
Overall physical activity adherence will be assessed with the LTPA questionnaire measured as weekly kilocalorie/week expended.
This outcome will be measured at baseline (program intake), at program completion (four to six months from baseline)and at 16 to 20 months from baseline.
|
Data collection to be completed in September 2011
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Scott Lear, PhD, Simon Fraser University
- Principal Investigator: Alejandra Farias-Godoy, MD, MSc, Simon Fraser University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 37553 (Other Identifier: Simon Fraser University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuNot yet recruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Reduced cardiac rehabilitation group intervention (rCRP).
-
University of BeykentIstanbul University - Cerrahpasa (IUC)UnknownOpen Heart SurgeryTurkey
-
Université de SherbrookeActive, not recruiting
-
Health Education Research Foundation (HERF)CompletedCardiac RehabilitationPakistan
-
National Heart and Lung InstituteRoyal Brompton & Harefield NHS Foundation TrustCompletedMicrovascular AnginaUnited Kingdom
-
Rigshospitalet, DenmarkUniversity Hospital, Gentofte, Copenhagen; Copenhagen Trial Unit, Center for...CompletedInfective EndocarditisDenmark
-
Universidad Rey Juan CarlosUnknownCardiovascular Diseases | Physical Disability | Treatment Adherence | Satisfaction | Adherence, PatientSpain
-
The University of Hong KongRecruitingCoronary Artery DiseaseHong Kong
-
Associacao de Investigacao de Cuidados de Suporte...Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.; University Institute...CompletedCardiovascular Diseases | Oncologic DisordersPortugal
-
University of MalagaRecruitingFrail Elderly Syndrome | Sarcopenia | Heart Failure With Preserved Ejection Fraction | Comorbidities and Coexisting ConditionsSpain
-
National University, SingaporeNational University Hospital, SingaporeRecruitingMyocardial InfarctionSingapore